BRIEF published on 09/02/2024 at 18:30, 2 months 21 days ago Cairn Homes Plc Announces Total Voting Rights Ordinary Shares Total Voting Rights Cairn Homes Transparency Regulations 636,642,951
PRESS RELEASE published on 09/02/2024 at 18:25, 2 months 21 days ago Cairn Homes Plc: Total Voting Rights Cairn Homes Plc confirms total voting rights of 636,642,951 Ordinary Shares. Shareholders use this figure for transparency regulations. Company focuses on sustainable new homes in prime locations Cairn Homes Plc Community Development Total Voting Rights Transparency Directive New Homes
BRIEF published on 09/02/2024 at 08:05, 2 months 21 days ago Cairn Homes Plc: Transaction in Own Shares Ordinary Shares Share Buyback Euronext Dublin Stock Exchange Goodbody Stockbrokers
PRESS RELEASE published on 09/02/2024 at 08:00, 2 months 21 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc repurchased 150,000 of its ordinary shares on Euronext Dublin and the London Stock Exchange. Shares will be cancelled as part of the buyback program London Stock Exchange Share Buyback Cairn Homes Plc Euronext Dublin Cancellation
BRIEF published on 08/30/2024 at 08:05, 2 months 24 days ago Cairn Homes Plc Announces Share Repurchase Share Repurchase Market Abuse Regulation Euronext Dublin Buyback Programme Goodbody Stockbrokers
PRESS RELEASE published on 08/30/2024 at 08:00, 2 months 24 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc purchased 150,000 of its ordinary shares for cancellation as part of the share buyback program. Company's total shares post-cancellation: 636,943,251 London Stock Exchange Ordinary Shares Share Buyback Cairn Homes Plc Euronext Dublin
BRIEF published on 08/29/2024 at 08:05, 2 months 25 days ago Cairn Homes Plc: Transaction in Own Shares London Stock Exchange Share Buyback Euronext Dublin Cairn Homes 2024 Transactions
BRIEF published on 08/29/2024 at 08:05, 2 months 25 days ago Cairn Homes Plc Appoints Bernard Byrne as Non-Executive Director and Chair-Designate Cairn Homes Plc Leadership Transition Non-Executive Director Bernard Byrne Homebuilding Industry
PRESS RELEASE published on 08/29/2024 at 08:00, 2 months 25 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc repurchases 147,651 of its ordinary shares at varying prices on Euronext Dublin and LSE as part of share buyback program, shares to be cancelled Ordinary Shares Share Buyback Cairn Homes Plc Repurchase Cancellation
PRESS RELEASE published on 08/29/2024 at 08:00, 2 months 25 days ago Cairn Homes Plc: Appointment of Non-Executive Director & Chair-Designate Cairn Homes Plc appoints Bernard Byrne as non-executive Director & Chair-Designate, succeeding John Reynolds in April 2025. Byrne brings leadership & financial expertise Cairn Homes Plc Non-Executive Director Leadership Bernard Byrne Chair-Designate
Published on 11/22/2024 at 23:55, 22 hours 47 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 23 hours 12 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 23 hours 37 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 4 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 day 4 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 5 hours ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/21/2024 at 06:58, 2 days 15 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 3 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 4 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 4 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
